A new projection study estimates that nearly a third of women aged 22 to 44 will have been diagnosed with a cardiovascular disease by 2050 ...

Researchers worldwide now have access to the largest pool of make-on-demand molecules. KYIV, UKRAINE, February 25, 2026 ...

Columbia University Mailman School of Public Health has received an award as part of the PROactive Solutions for Prolonging Resilience (PROSPR) program within the Advanced Research Projects Agency for ...

A major study of over 103,000 people found that eating after 8 p.m. significantly raises cardiovascular risk — and the ...

Hypertension and heart failure affect millions worldwide. Yet in many patients, doctors cannot fully explain why the heart ...

Deep in our cells, a wide range of processes are occurring constantly. These cellular processes rely on enzymes to act as catalysts and set off a series of molecular interactions. There are still many ...

A growing body of research suggests ACE inhibitors — one of the most commonly prescribed blood pressure medications — may slow biological aging at the cellular level, even when started later in life.

Many of us would probably like to forget sitting through math classes in school. But let’s briefly travel back, just for a ...

Living cells are sustained by countless chemical reactions that must be carefully regulated to maintain internal order and ...

Researchers have developed cyborg pancreatic tissue using an electrically conductive mesh, which has the potential to treat diabetes.

IRB Barcelona has launched Spain’s first fully integrated spatial omics platform, allowing researchers to capture cells' ...

Monitoring and treating heart failure (HF) is a challenging condition at any age. Several models, such as Atrial fibrillation, Hemoglobin, Elderly, Abnormal renal parameters, Diabetes mellitus (AHEAD) ...